Hollingsworth Jane H
Insider CIK 1297141 · DFFN Director · PATH Chief Executive Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CRVO CervoMed Inc. | A Award deriv | 2026-06-08 | 2026-06-10 | 8,150 | — | $0 | 8,150 | SEC↗ |
| CRVO CervoMed Inc. | A Award deriv | 2025-06-23 | 2025-06-25 | 8,100 | — | $0 | 8,100 | SEC↗ |
| CRVO CervoMed Inc. | A Award deriv | 2024-06-14 | 2024-06-14 | 5,750 | — | $0 | 5,750 | SEC↗ |
| CRVO CervoMed Inc. | A Award deriv | 2023-09-15 | 2023-09-15 | 6,450 | — | $0 | 6,450 | SEC↗ |
| CRVO CervoMed Inc. | M Exercise deriv | 2023-08-31 | 2023-09-06 | 122 | — | $0 | 0 | SEC↗ |
| CRVO CervoMed Inc. | M Exercise | 2023-08-31 | 2023-09-06 | 122 | — | $0 | 943 | SEC↗ |
| CRVO CervoMed Inc. | D To issuer | 2023-08-31 | 2023-09-06 | 45 | — | $0 | 898 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | M Exercise deriv | 2023-05-31 | 2023-06-02 | 183 | — | $0 | 183 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | D To issuer | 2023-05-31 | 2023-06-02 | 68 | — | $0 | 1,231 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | M Exercise | 2023-05-31 | 2023-06-02 | 183 | — | $0 | 1,299 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | M Exercise deriv | 2023-02-28 | 2023-03-03 | 183 | — | $0 | 366 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | D To issuer | 2023-02-28 | 2023-03-03 | 68 | — | $0 | 1,116 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | M Exercise | 2023-02-28 | 2023-03-03 | 183 | — | $0 | 1,184 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | M Exercise deriv | 2022-11-30 | 2022-12-02 | 183 | — | $0 | 549 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | M Exercise | 2022-11-30 | 2022-12-02 | 183 | — | $0 | 1,069 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | D To issuer | 2022-11-30 | 2022-12-02 | 68 | — | $0 | 1,001 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | M Exercise deriv | 2022-08-31 | 2022-09-02 | 183 | — | $0 | 732 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | M Exercise | 2022-08-31 | 2022-09-02 | 183 | — | $0 | 954 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | D To issuer | 2022-08-31 | 2022-09-02 | 67 | — | $0 | 886 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | M Exercise deriv | 2022-05-31 | 2022-06-02 | 183 | — | $0 | 915 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | M Exercise | 2022-05-31 | 2022-06-02 | 183 | — | $0 | 838 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | D To issuer | 2022-05-31 | 2022-06-02 | 67 | — | $0 | 771 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | A Award deriv | 2021-07-01 | 2021-07-06 | 83,300 | — | $0 | 83,300 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | P Buy | 2021-05-13 | 2021-05-17 | 32,786 | $0.61 | $20.0K | 32,786 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | A Award deriv | 2020-09-01 | 2020-10-01 | 54,900 | — | $0 | 54,900 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | A Award deriv | 2020-09-01 | 2020-10-01 | 67,400 | — | $0 | 67,400 | SEC↗ |
| PATH NUPATHE INC. | A Award deriv | 2012-03-08 | 2012-03-27 | 115,650 | — | $0 | 115,650 | SEC↗ |